Clinical Trial Update: An Observational Study For Ambrisentan

View source ↗

Summary

This document reports a completed observational study of ambrisentan conducted by GlaxoSmithKline, focusing on pulmonary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• LETAIRIS (ambrisentan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension, Pulmonary | Status: COMPLETED